The Role of Biomarkers in the Occurrence and Development of Asthma
ConditionAsthma in Children
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age4-12
SponsorChildren's Hospital of Chongqing Medical University
About this trial
To study the expression level of biomarkers such as GITRL in peripheral blood of children with asthma and analyze their correlation with the severity of asthma. To study the predictive value of biomarkers level for the occurrence and development of asthma. And to provide supplementary detection means and predictive indicators for the diagnosis of asthma and the severity of asthma.
Eligibility criteria
Qualifiers
In line with the diagnostic criteria in the Guidelines for the Diagnosis and Prevention of Bronchial Asthma in Children (2016 Edition)
Age: 4-12 years old for new diagnosis or recurrent episodes
Typical clinical manifestations and complete clinical data
Family members or guardians of children with informed research and signed consent
Disqualifiers
Suffering from other respiratory diseases (such as bronchiectasis, allergic rhinitis, respiratory failure, tuberculosis, obstructive airway disease) or other inflammatory diseases.
Abnormal development of congenital airway and lung tissue
History of immunosuppressant or glucocorticoid use in the first 4 weeks
Suffering from other endocrine system and immune system diseases
Trial design
Treatments tested in this trial
- The level of biomarkers in Peripheral blood
Treatment groups
2 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov